Various companies receive updated analyst ratings and consensus recommendations

Various publicly traded companies have recently received updated consensus ratings and price targets from financial analysts.

South Plains Financial, Inc. holds a “Moderate Buy” consensus from seven analysts, with an average 12-month target price of $49.60. C4 Therapeutics, Inc. also maintains a “Moderate Buy” rating from seven firms, despite a recent “sell” rating from Weiss Ratings.

Cronos Group Inc. has a consensus “Hold” rating from five brokerages. Cimpress plc has earned an average “Moderate Buy” from five brokerages, while TechnipFMC plc holds a “Moderate Buy” consensus from sixteen analysts, with twelve issuing buy ratings.

Recent earnings and insider activities were also noted, including share sales by directors at South Plains Financial and executives at Cimpress.